Modified Luciferase Substrate Specificity Mutation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing firefly luciferase enzymes maintain high reactivity with D-luciferin, making it impossible to construct a luminescent system that specifically reacts with substrates having emission wavelengths different from D-luciferin, limiting applications such as multicolor imaging techniques.

Innovation Solution

Modified luciferase enzymes with mutations at specific amino acid positions, particularly the 347th amino acid, are developed to enhance substrate specificity for other-color luminescent substrates like AkaLumine, reducing reactivity with D-luciferin while maintaining or improving reactivity with alternative substrates.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If firefly luciferase maintains high reactivity with D-luciferin, then the luminescent system works efficiently with the natural substrate, but it cannot specifically react with other-color luminescent substrates having different emission wavelengths

Engineering Contradiction:
Improvesubstrate specificityVSAvoidreactivity with D-luciferin
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent applies parameter changes by mutating specific amino acid residues in the firefly luciferase sequence (particularly positions 347, 229, and 310) to alter the enzyme's substrate binding properties. These parameter changes in the protein structure enable the modified luciferase to recognize and react with other-color luminescent substrates like AkaLumine while reducing reactivity with D-luciferin, thus achieving improved substrate specificity for different emission wavelengths

Inventive Principle:
Principle #35Parameter changes

2Adaptability or versatility

If the luminescent system uses D-luciferin as substrate, then it achieves reliable light emission, but it limits the ability to perform multicolor imaging techniques requiring different emission wavelengths

Engineering Contradiction:
Improveapplication rangeVSAvoidemission wavelength control
Core Design Contradiction:
Adaptability or versatilityVSIllumination intensity

Solution Approach 1:

By changing the amino acid parameters at key positions in the luciferase sequence, the patent enables the enzyme to catalyze reactions with substrates that emit at different wavelengths. This allows the luminescent system to be adapted for multicolor imaging applications while maintaining controlled light emission through the specific substrate-enzyme pairing

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The modified luciferase enzymes exhibit significantly improved substrate specificity for other-color luminescent substrates, allowing for higher emission intensity and increased specificity, enabling more versatile applications in biotechnology and imaging techniques.

Implementation Method 1

Light emission from fireflies, widely known as bioluminescence, occurs due to a reaction of a luminescent system of firefly luciferin (D-luciferin)-firefly luciferase

Methodology Applied
Scientific EffectBioluminescence: Bioluminescence

Implementation Method 2

a luminescent system of D-luciferin-luminescent Coleoptera luciferase can be used for analyzing efficiencies of gene expression

Methodology Applied
Scientific EffectChemiluminescence: Chemiluminescence

Data Source

PatentEP3505625B1Modified luciferase
Publication Date: 2021.05.12 RIKEN CO LTD
  • EP3505625B1 patent drawingFigure 1
  • EP3505625B1 patent drawing
  • EP3505625B1 patent drawing

AI summary

In order to provide modified luciferase whose substrate specificity to at least one luminescent substrate (e.g., AkaLumine) other than D-luciferin has been improved as compared with to D-luciferin, modified luciferase according to an aspect of the present invention has a mutation at an amino acid corresponding to a 347th amino acid in an amino acid sequence represented by SEQ ID NO: 1.